Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice

English version České info

Family with sequence similarity 20,-member C (FAM20C) is highly expressed in the mineralized tissues of mammals. Genetic studies showed that the loss-of-function mutations in FAM20C were associated with human lethal osteosclerotic bone dysplasia (Raine Syndrome), implying an inhibitory role of this molecule in bone formation. However, in vitro gain- and loss-of-function studies suggested that FAM20C promotes the differentiation and mineralization of mouse mesenchymal cells and odontoblasts. Recently, we generated Fam20c conditional knockout (cKO) mice in which Fam20c was globally inactivated (by crossbreeding with Sox2-Cre mice) or inactivated specifically in the mineralized tissues (by crossbreeding with 3.6 kb Col 1a1-Cre mice). Fam20c transgenic mice were also generated and crossbred with Fam20c cKO mice to introduce the transgene in the knockout background. In vitro gain- and loss-of-function were examined by adding recombinant FAM20C to MC3T3-E1 cells and by lentiviral shRNA–mediated knockdown of FAM20C in human and mouse osteogenic cell lines. Surprisingly, both the global and mineralized tissue-specific cKO mice developed hypophosphatemic rickets (but not osteosclerosis), along with a significant downregulation of osteoblast differentiation markers and a dramatic elevation of fibroblast growth factor 23 (FGF23) in the serum and bone. The mice expressing the Fam20c transgene in the wild-type background showed no abnormalities, while the expression of the Fam20c transgene fully rescued the skeletal defects in the cKO mice. Recombinant FAM20C promoted the differentiation and mineralization of MC3T3-E1 cells. Knockdown of FAM20C led to a remarkable downregulation of DMP1, along with a significant upregulation of FGF23 in both human and mouse osteogenic cell lines. These results indicate that FAM20C is a bone formation “promoter” but not an “inhibitor” in mouse osteogenesis. We conclude that FAM20C may regulate osteogenesis through its direct role in facilitating osteoblast differentiation and its systemic regulation of phosphate homeostasis via the mediation of FGF23.

Vyšlo v časopise: Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice. PLoS Genet 8(5): e32767. doi:10.1371/journal.pgen.1002708
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002708

Souhrn

Zdroje

1. NalbantDYounHNalbantSISharmaSCobosE 2005 FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics 6 11

2. AnCIdeYNagano-FujiiMKitazawaSShojiI 2010 A transgenic mouse line with a 58-kb fragment deletion in chromosome 11E1 that encompasses part of the Fam20a gene and its upstream region shows growth disorder. Kobe J Med Sci 55 4 E82 92

3. O'SullivanJBituCCDalySBUrquhartJEBarronMJ 2011 Whole-Exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome. Am J Hum Genet 88 5 616 620

4. EamesBFYanYSwartzMLevicDSKnapikEW 2011 Mutations in fam20b and xylt1 reveal that cartilage matrix controls timing of endochondral ossification by inhibiting chondrocyte maturation. PLoS Genet 7 e1002246 doi:10.1371/journal.pgen.1002246

5. HaoJNarayananKMuniTRamachandranAGeorgeA 2007 Dentin matrix protein 4, a novel secretory calcium-binding protein that modulates odontoblast differentiation. J Biol Chem 282 15357 15365

6. SimpsonMAHsuRKeirLSHaoJSivapalanG 2007 Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development. Am J Hum Genet 81 906 912

7. WangXHaoJXieYSunYHernandezB 2010 Expression of FAM20C in the osteogenesis and odontogenesis of mouse. J Histochem Cytochem 58 11 957 967

8. SimpsonMAScheuerleAHurstJPattonMAStewartH 2009 Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia. Clin Genet 75 271 276

9. ADHR Consortium. 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26 3 345 348

10. The HYP Consortium. 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X linked hypophosphatemic rickets. Nat Genet 11 130 136

11. FengJQWardLMLiuSLuYXieY 2006 Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38 1310 1315

12. LarssonTMarsellRSchipaniEOhlssonCLjunggrenO 2004 Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145 3087 3094

13. Lorenz-DepiereuxBBastepeMBenet-PagèsAAmyereMWagenstallerJ 2006 DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38 1248 1250

14. Lorenz-DepiereuxBSchnabelDTiosanoDHäuslerGStromTM 2010 Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 86 2 267 272

15. WhiteKECarnGLorenz-DepiereuxBBenet-PagesAStromTM 2001 Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60 2079 2086

16. BoskeyAL 1997 Amorphous calcium phosphate: the contention of bone. J Dent Res 76 8 1433 1436

17. YeLMishinaYChenDHuangHDallasSL 2005 Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype. J Biol Chem 280 7 6197 6203

18. SabbaghYCarpenterTODemayMB 2005 Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci U S A 102 27 9637 9642

19. AbeYAbeTAidaYHaraYMaedaK 2004 Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells. J Bone Miner Res 19 8 1302 1307

20. WangXPSuomalainenMJorgezCJMatzukMMWernerS 2004 Follistatin regulates enamel patterning in mouse incisors by asymmetrically inhibiting BMP signaling and ameloblast differentiation. Dev Cell 7 5 719 730

21. FinchPWHeXKelleyMJUrenASchaudiesRP 1997 Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA 94 6770 6775

22. LeynsLBouwmeesterTKimSHPiccoloSDe RobertisEM 1997 Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell 88 747 756

23. BarkerNvan EsJHKuipersJKujalaPvan den BornM 2007 Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 7165 1003 1007

24. HsuSYLiangSGHsuehAJ 1998 Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol Endocrinol 12 12 1830 1845

25. HoeppnerLHSecretoFJRazidloDFWhitneyTJWestendorfJJ 2011 Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass. J Biol Chem 286 13 10950 10959

26. LeeNKSowaHHinoiEFerronMAhnJD 2007 Endocrine regulation of energy metabolism by the skeleton. Cell 130 3 456 469

27. NakashimaKZhouXKunkelGZhangZDengJM 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 17 29

28. LiuSGuoRSimpsonLGXiaoZSBurnhamCE 2003 Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278 37419 37426

29. SitaraDRazzaqueMSHesseMYoganathanSTaguchiT 2004 Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phexdeficient mice. Matrix Biol 23 421 432

30. KurosuHOgawaYMiyoshiMYamamotoMNandiA 2006 Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281 6120 6123

31. UrakawaIYamazakiYShimadaTIijimaKHasegawaH 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444 7120 770 774

32. ShimadaTMizutaniSMutoTYoneyaTHinoRTakedaS 2001 Cloning and characterization of FGF23 as a causative factor of tumor induced osteomalacia. Proc Natl Acad Sci USA 98 6500 6505

33. LiuSZhouJTangWJiangXRoweDW 2006 Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 291 E38 49

34. LiuSTangWFangJRenJLiH 2009 Novel regulators of Fgf23 expression and mineralization in Hyp bone. Mol Endocrinol 23 9 1505 1518

35. BastepeMJüppnerH 2008 Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9 2 171 180

36. Alizadeh NaderiASReillyRFMedscape 2010 Hereditary disorders of renal phosphate wasting. Nat Rev Nephrol 6 11 657 665

37. MasuyamaRStockmansITorrekensSVan LooverenRMaesCCarmelietP 2006 Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116 12 3150 3159

38. FarrowEGWhiteKE 2010 Recent advances in renal phosphate handling. Nat Rev Nephrol 6 4 207 17

39. MeyerRAJrMeyerMHGrayRWBrunsME 1987 Evidence that low plasma 1,25-dihydroxyvitamin D causes intestinal malabsorption of calcium and phosphate in juvenile X-linked hypophosphatemic mice. J Bone Miner Res 2 1 67 82

40. ZhangMYWangXWangJTCompagnoneNAMellonSH 2002 Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1α-hydroxylase gene expression in the proximal renal tubule. Endocrinology 143 587 595

41. TenenhouseHSMartelJGauthierCZhangMYPortaleAA 2001 Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1α-hydroxylase by phosphate. Endocrinology 142 1124 1129

42. MeyerRAJrMeyerMHMorganPLKiebzakGMRoosBA 1996 Effects of altered diet on serum levels of 1,25-dihydroxyvitamin D and parathyroid hormone in X-linked hypophosphatemic (Hyp and Gy). Bone 18 23 28

43. KiebzakGMRoosBAMeyerRAJr 1982 Secondary hyperparathyroidism in X-linked hypophosphatemic mice. Endocrinology 111 650 652

44. GattineniJBatesCTwombleyKDwarakanathVRobinsonML 2009 FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297 F282 291

45. QuarlesLD 2008 Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118 12 3820 3828

46. LuYFengJQ 2011 FGF23 in skeletal modeling and remodeling. Curr Osteoporos Rep 9 2 103 108

47. LiangXZhouQLiXSunYLuM 2005 PINCH1 plays an essential role in early murine embryonic development but is dispensable in ventricular cardiomyocytes. Mol Cell Biol 25 3056 3062

48. BeardCHochedlingerKPlathKWutzAJaenischR 2006 Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44 1 23 28

49. SwartzMEberhartJMastickGSKrullCE 2001 Sparking new frontiers: using in vivo electroporation for genetic manipulations. Dev Biol 233 13 21

50. InouyeM 1976 Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red-S. Congen Anom 16 171 173

51. SunYPrasadMGaoTWangXZhuQ 2010 Failure to process dentin matrix protein 1 (DMP1) into fragments leads to its loss of function in osteogenesis. J Biol Chem 285 41 31713 31722

52. FisherLWStubbsJYoungMF 1995 Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand 66 61 65

53. SunYLuYChenLGaoTD'SouzaR 2011 DMP1 processing is essential to dentin and jaw formation. J Dent Res 90 5 619 624

54. MillerSCOmuraTHSmithLJ 1985 Changes in dentin appositional rates during pregnancy and lactation in rats. J Dent Res 64 1062 1064

55. ZhouXZhangZFengJQDusevichVMSinhaKZhangH 2010 Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc Natl Acad Sci U S A 107 29 12919 12924

56. MaDZhangRSunYRiosHFHaruyamaN 2011 A novel role of periostin in postnatal tooth formation and mineralization. J Biol Chem 286 6 4302 4309

57. YuanBTakaiwaMClemensTLFengJQKumarR 2008 Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest 118 2 722 734